368 related articles for article (PubMed ID: 16264178)
1. Paternity following treatment for testicular cancer.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
[TBL] [Abstract][Full Text] [Related]
2. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
3. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
4. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.
Jacobsen KD; Ous S; Waehre H; Trasti H; Stenwig AE; Lien HH; Aass N; Fosså SD
Br J Cancer; 1999 Apr; 80(1-2):249-55. PubMed ID: 10390004
[TBL] [Abstract][Full Text] [Related]
5. Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy.
Jacobsen KD; Theodorsen L; Fossa SD
J Urol; 2001 Jan; 165(1):93-6. PubMed ID: 11125372
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients with testicular cancer: a comparative analysis according to therapeutic modalities.
Miyake H; Muramaki M; Eto H; Kamidono S; Hara I
Oncol Rep; 2004 Oct; 12(4):867-70. PubMed ID: 15375514
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
8. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
Magelssen H; Haugen TB; von Düring V; Melve KK; Sandstad B; Fosså SD
Eur Urol; 2005 Nov; 48(5):779-85. PubMed ID: 15963629
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
10. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
11. Doctor ... will I still be able to have children?
Saxman S
J Natl Cancer Inst; 2005 Nov; 97(21):1557-9. PubMed ID: 16264170
[No Abstract] [Full Text] [Related]
12. Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.
Eberhard J; Ståhl O; Giwercman Y; Cwikiel M; Cavallin-Ståhl E; Lundin KB; Flodgren P; Giwercman A
Hum Reprod; 2004 Jun; 19(6):1418-25. PubMed ID: 15105386
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial aspects in long-term survivors of testicular cancer.
Arai Y; Kawakita M; Hida S; Terachi T; Okada Y; Yoshida O
J Urol; 1996 Feb; 155(2):574-8. PubMed ID: 8558663
[TBL] [Abstract][Full Text] [Related]
14. Mortality after cure of testicular seminoma.
Zagars GK; Ballo MT; Lee AK; Strom SS
J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
Stephenson AJ; Tal R; Sheinfeld J
J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
[TBL] [Abstract][Full Text] [Related]
16. Gonadal function in men with testicular cancer.
Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure and body mass index in long-term survivors of testicular cancer.
Sagstuen H; Aass N; Fosså SD; Dahl O; Klepp O; Wist EA; Wilsgaard T; Bremnes RM
J Clin Oncol; 2005 Aug; 23(22):4980-90. PubMed ID: 16051950
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
20. What are the chances of infertility and should sperm be banked?
Ohl DA; Sonksen J
Semin Urol Oncol; 1996 Feb; 14(1):36-44. PubMed ID: 8833388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]